Bank of America’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,800
| Closed | -$7K | – | 7378 |
|
|
2019
Q4 | $7K | Buy |
+1,800
| New | +$14.5K | ﹤0.01% | 6716 |
|
|
2018
Q4 | – | Sell |
-2,200
| Closed | -$37K | – | 7473 |
|
|
2018
Q3 | $37K | Buy |
+2,200
| New | +$47.6K | ﹤0.01% | 6331 |
|
|
2018
Q1 | – | Sell |
-20,000
| Closed | -$379K | – | 7413 |
|
|
2017
Q4 | $379K | Buy |
+20,000
| New | +$362K | ﹤0.01% | 5112 |
|
|
2015
Q1 | – | Sell |
-1,900
| Closed | -$13K | – | 7691 |
|
|
2014
Q4 | $13K | Buy |
1,900
+600
| +46% | +$4.41K | ﹤0.01% | 6973 |
|
|
2014
Q3 | $11K | Buy |
1,300
+500
| +63% | +$3.91K | ﹤0.01% | 7296 |
|
|
2014
Q2 | $7K | Sell |
800
-3,200
| -80% | -$24.3K | ﹤0.01% | 7584 |
|
|
2014
Q1 | $31K | Sell |
4,000
-2,600
| -39% | -$22K | ﹤0.01% | 6702 |
|
|
2013
Q4 | $58K | Buy |
6,600
+4,400
| +200% | +$39.3K | ﹤0.01% | 6478 |
|
|
2013
Q3 | $18K | Buy |
2,200
+600
| +38% | +$4.86K | ﹤0.01% | 6933 |
|
|
2013
Q2 | $12K | Buy |
+1,600
| New | +$12.3K | ﹤0.01% | 7130 |
|
Bank of America's SPPI Position: Q3 2023 in Review
Bank of America sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 97,803 shares — an estimated $93.9K sold.
Bank of America first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $8.76M in Q4 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Bank of America reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Bank of America sold 97,803 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $93.9K.
- Bank of America first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
- Bank of America's Spectrum Pharmaceuticals Inc position peaked at $8.76M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.